AssetMark Inc’s Assembly Biosciences ASMB Stock Holding History

AssetMark Inc’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3	Closed	-$2K	–	1442
2017 Q4	$2K	Buy	+3	New	+$1.36K	﹤0.01%	1420

Other funds holding ASMB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AssetMark Inc's ASMB Position: Q1 2018 in Review

AssetMark Inc sold out of Assembly Biosciences (ASMB) in Q1 2018, closing a stake of 3 shares — an estimated $2K sold.

AssetMark Inc first reported a position in ASMB in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 107 funds tracked by Wall St. Rank hold ASMB as of Q1 2018.

AssetMark Inc reported no remaining Assembly Biosciences position as of Q1 2018 after selling out during the quarter.
AssetMark Inc sold 3 Assembly Biosciences shares in Q1 2018, an estimated $2K.
AssetMark Inc first reported a position in Assembly Biosciences in Q4 2017 and held it in 1 quarter.
AssetMark Inc's Assembly Biosciences position peaked at $2K in Q4 2017.
107 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2018.

Based on AssetMark Inc's 13F filing for Q1 2018, filed 16 May 2018.